Sanofi Receives Complete Response Letter from FDA for MS Treatment

Elis announced that its Management Board has decided to reduce its share capital, under the authorization granted by the General Meetings of May 2024 and May 2025, by cancelling 4,705,107 treasury shares, representing 1.98% of the capital.…